Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the ...

Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...

Despite the staggering impact of obesity on the Black community, columnist Justice B. Hill argues that the issue has been ...

Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema ...

The way clinicians diagnose obesity is set to change with new guidelines acknowledging that not all obese have the same ...

Researchers at LSU’s Pennington Biomedical Research Center are working with the Lancet Commission on Clinical Obesity, in ...

An international panel of researchers say the measure is too simplistic and focuses too much on weight versus wellness.

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...